Comparison Across Multiple Types of Sleep Deprivation

NCT ID: NCT04211506

Last Updated: 2023-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

59 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-08-25

Study Completion Date

2023-09-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to assess neurobehavioral performance, as well as genetic and other physiological changes associated with variations in timing and quantity of sleep.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

During a 1.5 week inpatient laboratory protocol, subjects will undergo one of four parallel sleep conditions. Subjects will be randomly assigned to each condition group. During their time in the laboratory, biological samples (e.g., blood) will be collected for genetic and other analyses, and sleep quantity and quality will be monitored. Additionally responses on neurobehavioral tests and surveys will be monitored for differences among the groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Deprivation Sleep Restriction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Each participant will undergo one of four separate arms manipulating levels and timing of sleep in a controlled laboratory setting.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants
Participants may not know to which study arm they are assigned.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sleep Arm 1

This will be the first of four arms of controlled sleep manipulation.

Group Type EXPERIMENTAL

Controlled sleep

Intervention Type BEHAVIORAL

Duration and timing of sleep will be assigned and monitored in a controlled laboratory environment with controlled lighting and meals.

Sleep Arm 2

This will be the second of four arms of controlled sleep manipulation.

Group Type EXPERIMENTAL

Controlled sleep

Intervention Type BEHAVIORAL

Duration and timing of sleep will be assigned and monitored in a controlled laboratory environment with controlled lighting and meals.

Sleep Arm 3

This will be the third of four arms of controlled sleep manipulation.

Group Type EXPERIMENTAL

Controlled sleep

Intervention Type BEHAVIORAL

Duration and timing of sleep will be assigned and monitored in a controlled laboratory environment with controlled lighting and meals.

Sleep Arm 4

This will be the fourth of four arms of controlled sleep manipulation.

Group Type EXPERIMENTAL

Controlled sleep

Intervention Type BEHAVIORAL

Duration and timing of sleep will be assigned and monitored in a controlled laboratory environment with controlled lighting and meals.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Controlled sleep

Duration and timing of sleep will be assigned and monitored in a controlled laboratory environment with controlled lighting and meals.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy
* BMI 18.5-29.9, with consideration of BMIs 30-34.9.

Exclusion Criteria

* Medication use, with potential consideration for contraceptives.
* Color blindness
* Recent nightwork, shiftwork, or travel across greater than two time zones
* Pregnant or within 6 months post-partum
Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Brigham and Women's Hospital

OTHER

Sponsor Role collaborator

Civil Aerospace Medical Institute

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hilary Uyhelji, PhD

Role: PRINCIPAL_INVESTIGATOR

FAA Civil Aerospace Medical Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brigham and Women's Hospital

Boston, Massachusetts, United States

Site Status

FAA Civil Aerospace Medical Institute

Oklahoma City, Oklahoma, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GEN10025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fatigue in Short-Haul Operations
NCT05524441 RECRUITING